Volume : 12, Issue : 02, February – 2025

Title:

STUDY ON ASSESSMENT AND MONITORING OF ADVERSE DRUG REACTIONS PEOPLE USING CORTICOTEROIDS & AWARENESS ABOUT CORTICOSTEROIDS.
‬

Authors :

Udhayakumar.P. Rekha.V.S. Suba Varshini.S. Nivetha.A. Vidhya.G

Abstract :

The study focuses on assessing and monitoring adverse drug reactions (ADRs) in individuals using corticosteroids and evaluating the level of awareness regarding these medications. Corticosteroids, widely prescribed for a variety of conditions, are associated with a range of potential side effects. However, despite their widespread use, both healthcare professionals and patients often demonstrate limited understanding of these drugs’ risks and proper usage. This research aims to identify common ADRs related to corticosteroid use, the effectiveness of current monitoring systems, and the level of knowledge patients and healthcare providers possess about these medications. The study employs a combination of surveys, clinical assessments, and literature review to gather data. The results highlight the need for improved education, better monitoring practices, and a proactive approach to managing corticosteroid therapy to minimize potential harm. The findings advocate for targeted interventions to increase awareness among both patients and healthcare professionals.
Keywords: Adverse Drug Reactions (ADRs), Corticosteroids, Medication Awareness, Pharmacovigilance, Drug Monitoring, Patient Education, Healthcare Providers, Side Effects, Pharmacotherapy Management, Corticosteroid Therapy

Cite This Article:

Please cite this article in press Rekha.V.S et al., Study On Assessment And Monitoring Of Adverse Drug Reactions People Using Corticoteroids & Awareness About Corticosteroids.,Indo Am. J. P. Sci, 2025; 12 (02).

Number of Downloads : 10

References:

1. Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am AcadDermatol. 2006; 54:1-15.
2. Schoepe S, Schacke H, May E, Asadullah K. Glucocorticoid therapy-induced skin Atrophy. ExpDermatol. 2006:15:406-20.
3. Fixed Dose Combinations approved By DCG (I) since 1961 till July, 2014. Central Drugs Standard Control Organization, India.
4. Approval Status of New Drug during 1971- 1998. Central Drugs Standard Control Organization, India. Available from: http://cdsco.nic.in/ writereaddata/1971- 98.doc. [Last accessed on 2016 Dec 29].
5. Saraswat A, Lahiri K, Chatterjee M, Barua S, Coondoo A, Mittal A, et al. Topical corticosteroid abuse on the face: A prospective, multicenter study of dermatology outpatients. Indian J DermatolVenereolLeprol. 2011; 77:160-6.
6. Ambika H, VinodCS, Yadalla H, NithyaR, BabuAR. Topical corticosteroids abuse on face: A prospective, study on outpatients of dermatology. Our Dermatol Online. 2014; 5:5- 8.
7. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998; 279: 1200–5.
8. Beijer HJM, de Blaey CJ. Hospitalisations caused by adverse drug reactions: a meta-analysis of observational studies. Pharm World Sci. 2002; 24: 46–54.
9. Dhikar V, Singh S, Anand KS. Adverse drug reaction monitoring in India. J IndAcadClin Med. 2004; 5: 27–33.
10. Van-Grootheest AC, De Jong-van den Berg LT. The role of hospital and community pharmacists in pharmacovigilance. Research in Social and Administrative Pharmacy. 2005;1(1):126-133.